Peptable

Comparison

CJC-1295 vs Melanotan I

Function

While CJC-1295 is used in research to chronically elevate endogenous growth hormone and IGF-1 levels, enabling studies of body composition, metabolic, and anti-aging effects of prolonged GH exposure10, Melanotan I is approved in some regions for prevention of phototoxicity in erythropoietic protoporphyria and is studied as a skin-darkening, photoprotective peptide3444.

Mechanism

While CJC-1295 works as a tetrasubstituted 29-amino-acid analog of GHRH(1–29) that acts as a potent agonist at the GHRH receptor and, in its DAC form, covalently binds serum albumin to extend half-life from minutes to days, resulting in sustained pulsatile GH and IGF-1 increase1082, Melanotan I is a linear 13-amino-acid analog of α-MSH (afamelanotide) that selectively activates MC1R on melanocytes, increasing eumelanin synthesis and providing photoprotection3444.

Receptor

CJC-1295

Growth hormone–releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs1094103

Melanotan I

Melanocortin-1 receptor (MC1R) 344481

Organism or Origin

CJC-1295

Synthetic peptide based on human hypothalamic GHRH10120

Melanotan I

Synthetic analog of human α-MSH derived from POMC34448190

Gene

CJC-1295

GHRH

Melanotan I

POMC

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: CJC-1295 is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas Melanotan I is more often associated with the realm of Dermatology and aesthetics. Both appear to work through Receptor agonist, but the functional emphasis still separates, with CJC-1295 leaning toward Anabolic growth, Lipolysis and fat loss, and Metabolic regulation and Melanotan I leaning toward Melanogenesis modulation. Both are synthetic in origin with CJC-1295 in Preclinical development and Melanotan I approved for Research use only. CJC-1295 takes the form of a peptide conjugate, whereas Melanotan I is closer to a linear peptide, while their sequence patterns also diverge, with CJC-1295 showing alpha-helical domain features and Melanotan I showing protein-mimetic sequence features.

Sources

10CJC-1295: Long-Acting GHRH Analog - Alpha Carbon Labs, https://alphacarbonlabs.com/blog/cjc-1295-long-acting-ghrh-analog
82CJC-1295 no DAC 5mg (Mod GRF 1-29), https://www.peptidesciences.com/mod-grf-1-29-5mg-cjc-1295-no-dac
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
120Growth hormone–releasing hormone - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone%E2%80%93releasing_hormone
34Melanotan I (Afamelanotide): Research Profile - PeptideJournal, https://www.peptidejournal.org/peptides/melanotan-i-research-profile
44Melanotan I: properties, applications and references, https://www.benchchem.com/zh/product/b1666627
81Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is ..., https://pmc.ncbi.nlm.nih.gov/articles/PMC2253185/
90alpha-Melanocyte stimulating hormone: production and degradation, https://pmc.ncbi.nlm.nih.gov/articles/PMC3936413/